Oncology & Cancer

Enhanced CAR T cell therapy offers new strategy for lymphoma

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including commercially available ...

Oncology & Cancer

Protein linked to immunotherapy resistance in kidney cancer

A protein identified by researchers at UT Southwestern Medical Center may drive resistance to immune checkpoint inhibitors, a widely used form of immunotherapy to treat cancer. The findings, published in Communications Medicine, ...

page 2 from 40